Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40495-021-00253-w http://scihub22266oqcxt.onion/10.1007/s40495-021-00253-w 33619447!7889701!33619447     free     free     free Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Curr+Pharmacol+Rep 2021 ; 7 (2): 49-54 Nephropedia Template TP {{tp|p=33619447|t=2021. Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone |pdf=|usr=}}{{33619447}} gab.com Text Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone JO: Curr Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=33619447 #FOAvip PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome-coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanism, epidemiology, drugs, and vaccines. Many drugs and vaccines are being studied by researchers to treat and prevent the SARS-CoV-2. Favipiravir and dexamethasone are repurposed drugs which showed therapeutic potential and pharmaceutical efficacy against SARS-CoV-2. SUMMARY: The review describes the path of favipiravir and dexamethasone from chemistry to mechanisms of action to combat SARS-CoV-2. In addition, the potential side effects are also summarized to study their potential to control corona virus 2019. Twit Text FOAVip Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone ????Curr Pharmacol Rep http://www.kidney.de/pget.php?&tw=1&pmid=33619447 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33619447 #FOAvip English Wikipedia <ref>{{Cite pmid|33619447}}</ref> Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone #MMPMID33619447 Sood S; Bhatia GK; Seth P; Kumar P; Kaur J; Gupta V; Punia S; Tuli HS Curr Pharmacol Rep 2021[]; 7 (2): 49-54 PMID33619447show ga PURPOSE OF REVIEW: The widespread respiratory disease of virus known as severe acute respiratory syndrome-coronavirus 2019 (SAR-CoV-2) had infected more than 200 countries and caused pandemic and havoc in the world. RECENT FINDINGS: The genome of the virus was sequenced rapidly to study its mechanism, epidemiology, drugs, and vaccines. Many drugs and vaccines are being studied by researchers to treat and prevent the SARS-CoV-2. Favipiravir and dexamethasone are repurposed drugs which showed therapeutic potential and pharmaceutical efficacy against SARS-CoV-2. SUMMARY: The review describes the path of favipiravir and dexamethasone from chemistry to mechanisms of action to combat SARS-CoV-2. In addition, the potential side effects are also summarized to study their potential to control corona virus 2019. äEfficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravi(epmc).pdf DeepDyve Pubget Overpricing